 David Root
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 11 | 2023 | 45 | 4.850 |
Why?
| | Glutamic Acid | 9 | 2023 | 213 | 4.130 |
Why?
| | Cocaine | 12 | 2021 | 153 | 3.290 |
Why?
| | Neurons | 17 | 2022 | 1298 | 2.840 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 6 | 2022 | 12 | 2.220 |
Why?
| | GABAergic Neurons | 4 | 2023 | 22 | 2.030 |
Why?
| | Habenula | 6 | 2017 | 11 | 1.870 |
Why?
| | Behavior, Animal | 10 | 2021 | 472 | 1.820 |
Why?
| | Globus Pallidus | 5 | 2019 | 19 | 1.800 |
Why?
| | Cocaine-Related Disorders | 7 | 2013 | 107 | 1.690 |
Why?
| | Dopamine | 7 | 2023 | 237 | 1.620 |
Why?
| | Motivation | 6 | 2021 | 498 | 1.210 |
Why?
| | Basal Forebrain | 2 | 2019 | 2 | 1.190 |
Why?
| | gamma-Aminobutyric Acid | 6 | 2023 | 151 | 1.150 |
Why?
| | Behavior, Addictive | 2 | 2019 | 78 | 1.090 |
Why?
| | Action Potentials | 7 | 2014 | 410 | 1.030 |
Why?
| | Self Administration | 12 | 2021 | 124 | 1.010 |
Why?
| | Nucleus Accumbens | 4 | 2016 | 123 | 0.980 |
Why?
| | Conditioning, Operant | 7 | 2013 | 99 | 0.920 |
Why?
| | Septal Nuclei | 1 | 2023 | 17 | 0.890 |
Why?
| | Drug-Seeking Behavior | 3 | 2019 | 22 | 0.880 |
Why?
| | Oxycodone | 2 | 2023 | 44 | 0.870 |
Why?
| | Animals | 38 | 2023 | 32104 | 0.860 |
Why?
| | Reward | 3 | 2021 | 208 | 0.840 |
Why?
| | Neuropeptides | 1 | 2021 | 65 | 0.780 |
Why?
| | Fear | 2 | 2022 | 297 | 0.750 |
Why?
| | Rats | 20 | 2022 | 5033 | 0.730 |
Why?
| | Brain | 4 | 2022 | 2373 | 0.730 |
Why?
| | Rats, Long-Evans | 12 | 2014 | 100 | 0.710 |
Why?
| | Neural Pathways | 4 | 2014 | 260 | 0.700 |
Why?
| | Substance Abuse, Oral | 1 | 2019 | 1 | 0.690 |
Why?
| | Conditioning, Classical | 4 | 2013 | 87 | 0.690 |
Why?
| | Avoidance Learning | 2 | 2022 | 62 | 0.670 |
Why?
| | Glutamates | 1 | 2018 | 59 | 0.610 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2022 | 699 | 0.600 |
Why?
| | Synapses | 2 | 2018 | 336 | 0.590 |
Why?
| | Dopamine Uptake Inhibitors | 4 | 2013 | 54 | 0.580 |
Why?
| | Axons | 2 | 2018 | 179 | 0.560 |
Why?
| | Cues | 6 | 2021 | 298 | 0.560 |
Why?
| | Mesencephalon | 1 | 2016 | 57 | 0.540 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 783 | 0.530 |
Why?
| | Mice | 9 | 2023 | 15052 | 0.500 |
Why?
| | Receptors, Dopamine D4 | 1 | 2015 | 24 | 0.500 |
Why?
| | Neostriatum | 3 | 2022 | 29 | 0.490 |
Why?
| | Stress, Psychological | 1 | 2022 | 975 | 0.480 |
Why?
| | Tegmentum Mesencephali | 1 | 2014 | 4 | 0.480 |
Why?
| | Nerve Net | 1 | 2017 | 228 | 0.480 |
Why?
| | Norepinephrine | 1 | 2015 | 207 | 0.460 |
Why?
| | Male | 28 | 2023 | 56050 | 0.450 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 476 | 0.450 |
Why?
| | Motor Activity | 3 | 2015 | 633 | 0.430 |
Why?
| | Vocalization, Animal | 4 | 2013 | 28 | 0.410 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 422 | 0.410 |
Why?
| | Goals | 1 | 2013 | 158 | 0.410 |
Why?
| | Choice Behavior | 1 | 2013 | 159 | 0.410 |
Why?
| | Basal Ganglia | 1 | 2011 | 42 | 0.390 |
Why?
| | Motor Skills | 1 | 2011 | 80 | 0.360 |
Why?
| | Extinction, Psychological | 2 | 2009 | 80 | 0.350 |
Why?
| | Rats, Sprague-Dawley | 5 | 2018 | 2262 | 0.350 |
Why?
| | Association Learning | 1 | 2010 | 60 | 0.340 |
Why?
| | Dopaminergic Neurons | 2 | 2023 | 43 | 0.330 |
Why?
| | Cycloserine | 1 | 2007 | 3 | 0.300 |
Why?
| | Movement | 1 | 2010 | 246 | 0.300 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 37 | 0.300 |
Why?
| | Sleep Deprivation | 1 | 2007 | 166 | 0.250 |
Why?
| | Reaction Time | 5 | 2014 | 374 | 0.240 |
Why?
| | Brain Mapping | 2 | 2022 | 522 | 0.230 |
Why?
| | Corpus Striatum | 3 | 2022 | 124 | 0.220 |
Why?
| | Receptors, Opioid, mu | 1 | 2023 | 52 | 0.220 |
Why?
| | Mice, Inbred C57BL | 3 | 2022 | 4773 | 0.220 |
Why?
| | Behavior Control | 1 | 2022 | 14 | 0.210 |
Why?
| | Recurrence | 2 | 2019 | 953 | 0.210 |
Why?
| | Risk | 1 | 2005 | 819 | 0.200 |
Why?
| | Signal Transduction | 3 | 2021 | 4541 | 0.200 |
Why?
| | Histological Techniques | 1 | 2022 | 40 | 0.200 |
Why?
| | Workflow | 1 | 2022 | 136 | 0.190 |
Why?
| | Entopeduncular Nucleus | 1 | 2018 | 1 | 0.160 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 3 | 0.160 |
Why?
| | Synaptic Transmission | 2 | 2017 | 232 | 0.160 |
Why?
| | Analysis of Variance | 3 | 2012 | 1230 | 0.160 |
Why?
| | Ultrasonics | 3 | 2013 | 48 | 0.150 |
Why?
| | Synaptic Vesicles | 1 | 2018 | 37 | 0.150 |
Why?
| | Preoptic Area | 1 | 2017 | 6 | 0.150 |
Why?
| | Glutamate Decarboxylase | 1 | 2018 | 162 | 0.150 |
Why?
| | Tissue Distribution | 1 | 2018 | 324 | 0.150 |
Why?
| | Administration, Oral | 1 | 2019 | 734 | 0.140 |
Why?
| | Anxiety | 1 | 2023 | 854 | 0.140 |
Why?
| | Callithrix | 1 | 2016 | 8 | 0.140 |
Why?
| | Pars Compacta | 1 | 2016 | 4 | 0.140 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2016 | 68 | 0.140 |
Why?
| | Head Movements | 2 | 2013 | 18 | 0.140 |
Why?
| | Risk Assessment | 1 | 2005 | 2990 | 0.130 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2015 | 5 | 0.130 |
Why?
| | Dopamine Antagonists | 1 | 2015 | 22 | 0.120 |
Why?
| | Dopamine Agonists | 1 | 2015 | 31 | 0.120 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 40 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 56 | 0.120 |
Why?
| | Olfactory Tubercle | 1 | 2014 | 1 | 0.120 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 89 | 0.120 |
Why?
| | Sex Factors | 1 | 2019 | 1739 | 0.120 |
Why?
| | Electrophysiology | 2 | 2014 | 202 | 0.120 |
Why?
| | Microelectrodes | 1 | 2014 | 32 | 0.120 |
Why?
| | Piperidines | 1 | 2015 | 163 | 0.110 |
Why?
| | Locomotion | 1 | 2014 | 81 | 0.110 |
Why?
| | Electrodes, Implanted | 1 | 2014 | 92 | 0.110 |
Why?
| | Calbindins | 1 | 2013 | 5 | 0.110 |
Why?
| | S100 Calcium Binding Protein G | 1 | 2013 | 8 | 0.110 |
Why?
| | Neurotensin | 1 | 2013 | 11 | 0.110 |
Why?
| | Hypothalamus | 1 | 2014 | 150 | 0.110 |
Why?
| | Amphetamine | 1 | 2013 | 22 | 0.110 |
Why?
| | Substance P | 1 | 2013 | 44 | 0.110 |
Why?
| | Piperazines | 1 | 2015 | 314 | 0.100 |
Why?
| | Subthalamic Nucleus | 1 | 2013 | 38 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2013 | 1870 | 0.100 |
Why?
| | Female | 4 | 2022 | 60018 | 0.100 |
Why?
| | Probability | 1 | 2012 | 294 | 0.100 |
Why?
| | Satiety Response | 1 | 2011 | 8 | 0.100 |
Why?
| | Models, Biological | 1 | 2018 | 1646 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3122 | 0.090 |
Why?
| | Habits | 1 | 2010 | 37 | 0.090 |
Why?
| | Orientation | 1 | 2010 | 39 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2014 | 1970 | 0.080 |
Why?
| | Electroshock | 1 | 2009 | 140 | 0.080 |
Why?
| | Evoked Potentials | 1 | 2010 | 110 | 0.080 |
Why?
| | Head | 1 | 2010 | 86 | 0.080 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2007 | 23 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2015 | 2574 | 0.070 |
Why?
| | Sleep, REM | 1 | 2007 | 50 | 0.070 |
Why?
| | Psychomotor Performance | 1 | 2009 | 278 | 0.070 |
Why?
| | Humans | 6 | 2020 | 115741 | 0.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 182 | 0.070 |
Why?
| | Learning | 1 | 2009 | 358 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 724 | 0.060 |
Why?
| | United States Environmental Protection Agency | 1 | 2005 | 23 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2005 | 161 | 0.060 |
Why?
| | Pain | 1 | 2009 | 712 | 0.060 |
Why?
| | Receptors, Dopamine D1 | 1 | 2022 | 25 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2011 | 3580 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 310 | 0.050 |
Why?
| | Prefrontal Cortex | 1 | 2022 | 267 | 0.040 |
Why?
| | Research Design | 1 | 2005 | 946 | 0.040 |
Why?
| | Neurotransmitter Agents | 1 | 2016 | 77 | 0.030 |
Why?
| | Behavior | 1 | 2016 | 91 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2013 | 19 | 0.030 |
Why?
| | Reinforcement Schedule | 1 | 2012 | 29 | 0.030 |
Why?
| | Sweetening Agents | 1 | 2012 | 37 | 0.030 |
Why?
| | Sucrose | 1 | 2012 | 91 | 0.030 |
Why?
| | Video Recording | 1 | 2012 | 147 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2013 | 140 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 642 | 0.020 |
Why?
| | United States | 1 | 2005 | 12304 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2005 | 12633 | 0.020 |
Why?
| | Affect | 1 | 2010 | 244 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 951 | 0.020 |
Why?
| | Depression | 1 | 2016 | 1147 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 1825 | 0.020 |
Why?
|
|
Root's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|